Real Cases of Buprenorphine-Naloxone Treatment: What to do and how to do it?
This is the first of two 2019 webinars on Medication Assisted Treatment (MAT) in primary care settings created by the California Society of Addiction Medicine (CSAM) with the support of a grant from the California Department of Healthcare Services (DHCS).
Description: The number of X-waivered providers in California is increasing. Many primary care providers are now doing office-based care of patients with opioid use disorder. This webinar will showcase common, challenging situations that arise for patients being maintained on buprenorphine. Expert discussants will talk through cases to teach the learner practical management tips.
Webinar recorded on 2/13/2019.
PRICE/PURCHASE
ASAM and/or CSAM Members: Free
Non-Member: $50.00
You must register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart."
Credit
This enduring internet activity is directly provided by the California Society of Addiction Medicine (CSAM) with the support of a grant from the Department of Healthcare Services (DHCS). CSAM is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
PA’s, nurses, pharmacists, psychologists and therapists can earn CEU credit.
**CSAM accepts no funding from the pharmaceutical industry in creating this webinar or any of its educational programs.
Target Audience
- Primary Care Physician who are beginning or planning to integrate buprenorphine for the treatment of opioid dependence into their practice.
- Associated health professionals who work in a setting that treats opioid dependent patients.
Learning Objectives
- Be able to describe basic strategies to use for the patient on buprenorphine-naloxone treatment for Opioid Use Disorder (OUD) who is still using opioids.
- Understand different options for monitoring for a patient struggling while in office-based treatment.
- Model an example of communication techniques for challenging patient situations.
Soraya Azari, MD (Moderator)
Associate Professor of Medicine
Division of General Internal Medicine
University of California, San Francisco
San Francisco General Hospital
Kenneth Saffier, MD, FASAM
Lead Physician
Choosing Change Program
Contra Costa Health Services
Martinez, CA
Scott Steiger, MD, FACP, FASAM
Deputy Medical Director
Opiate Treatment Outpatient Program
San Francisco General Hospital
Soraya Azari, Kenneth Saffier, Scott Steiger and the Planners of this activity have no relevant financial relationships to disclose
This enduring internet activity is directly provided by the California Society of Addiction Medicine (CSAM) with the support of a grant from the Department of Healthcare Services (DHCS). CSAM is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
PA’s, nurses, pharmacists, psychologists and therapists can earn CEU credit.
Available Credit
- 1.00 AMA Category 1
- 1.00 Attendance